Background Idarucizumab has been approved to reverse the anticoagulant effect of
dabigatran. However, there is little knowledge of the effectiveness and safety of …

Direct oral anticoagulants (DOACs) are recommended for the prevention of
thromboembolism in patients with atrial fibrillation (AF), and are now preferred over vitamin …

Importance The temporal trend in adverse events regarding stroke prevention for
nonvalvular atrial fibrillation (NVAF) in the direct oral anticoagulant (DOAC) era was rarely …

Background: The aim of the study was to evaluate the performance of the 2MACE in patients
with atrial fibrillation (AF) treated with rivaroxaban and to improve the accuracy of 2MACE …

Introduction In the past decade, the atrial fibrillation (AF) landscape, including the treatment
modalities, has drastically changed. This raises the question how AF prevalence and …

A contact force sensor is a critical clinical unit while performing cardiac ablation procedures.
The success rate of these procedures is determined by the effective contact between the tip …

Aim: The aim of this pilot study is to determine the pattern of oral anticoagulant and
antiplatelet use in patients with permanent atrial fibrillation (AF) in Irish general practice …

Background Routine oral anticoagulation (OAC) is recommended for almost all high-risk
patients with atrial fibrillation, yet registries show that OACs are still underused. Our aim was …

Background. Patients with nonvalvular atrial fibrillation (NVAF) have five times higher risk of
stroke than the general population. Anticoagulation (ACO) in NVAF is a class I indication …

BACKGROUND The predictive value of bleeding risk scores for atrial fibrillation in older
patients is not as well known. The goal of this study was to evaluate the predictive value of …